Human papillomavirus-16/18 candidate vaccine adjuvanted with AS04 and its impact on the incidence of cervical cancer

Global cancer statistics

2011 • 55,498 citations

Global Cancer Statistics, 2002

2005 • 17,966 citations

Epidemiologic Classification of Human Papillomavirus Types Associated with Cervical Cancer

2003 • 6,072 citations

A human homologue of the Drosophila Toll protein signals activation of adaptive immunity

1997 • 5,522 citations

Toll-like receptors: critical proteins linking innate and acquired immunity

2001 • 4,673 citations

Cancer incidence, mortality and prevalence worldwide

2004 • 3,893 citations

Classification of papillomaviruses

2004 • 3,098 citations

MECHANISMS OF PHAGOCYTOSIS IN MACROPHAGES

1999 • 2,766 citations

SEER Cancer Statistics Review, 1975-2008, National Cancer Institute, Bethesda, MD

2011 • 2,409 citations

Sustained efficacy up to 4·5 years of a bivalent L1 virus-like particle vaccine against human papillomavirus types 16 and 18: follow-up from a randomised control trial

2006 • 1,766 citations

Host Defense Mechanisms Triggered by Microbial Lipoproteins Through Toll-Like Receptors

1999 • 1,679 citations

Efficacy of a bivalent L1 virus-like particle vaccine in prevention of infection with human papillomavirus types 16 and 18 in young women: a randomised controlled trial

2004 • 1,624 citations

Human papillomavirus types in invasive cervical cancer worldwide: a meta-analysis

2003 • 1,535 citations

Toll-like receptors control activation of adaptive immune responses

2001 • 1,374 citations

2001 Consensus Guidelines for the Management of Women With Cervical Cytological Abnormalities

2002 • 1,232 citations

Cutting Edge: Repurification of Lipopolysaccharide Eliminates Signaling Through Both Human and Murine Toll-Like Receptor 2

2000 • 1,173 citations

Against which human papillomavirus types shall we vaccinate and screen? the international perspective

2004 • 1,099 citations

Worldwide distribution of human papillomavirus types in cytologically normal women in the International Agency for Research on Cancer HPV prevalence surveys: a pooled analysis

2005 • 1,063 citations

Recommendations of the Advisory Committee on Immunization Practices (ACIP)

2008 • 1,052 citations

Comparison of Three Management Strategies for Patients With Atypical Squamous Cells of Undetermined Significance: Baseline Results From a Randomized Trial

2001 • 997 citations

The epidemiology of human papillomavirus infections

2005 • 935 citations

American Cancer Society Guideline for the Early Detection of Cervical Neoplasia and Cancer

2002 • 930 citations

The Rising Incidence of Adenocarcinoma Relative to Squamous Cell Carcinoma of the Uterine Cervix in the United States—A 24-Year Population-Based Study

2000 • 691 citations

Systemic immunization with papillomavirus L1 protein completely prevents the development of viral mucosal papillomas.

1995 • 683 citations

Comparison of HPV type distribution in high-grade cervical lesions and cervical cancer: a meta-analysis

2003 • 680 citations

Population-Based Study of Human Papillomavirus Infection and Cervical Neoplasia in Rural Costa Rica

2000 • 611 citations

Immunization with viruslike particles from cottontail rabbit papillomavirus (CRPV) can protect against experimental CRPV infection

1995 • 597 citations

Human Papillomavirus Genotype Distribution in Low-Grade Cervical Lesions: Comparison by Geographic Region and with Cervical Cancer

2005 • 532 citations

HUMAN GENITAL CANCER: SYNERGISM BETWEEN TWO VIRUS INFECTIONS OR SYNERGISM BETWEEN A VIRUS INFECTION AND INITIATING EVENTS?

1982 • 490 citations

Enhanced humoral and memory B cellular immunity using HPV16/18 L1 VLP vaccine formulated with the MPL/aluminium salt combination (AS04) compared to aluminium salt only

2006 • 480 citations

Natural history of cervical squamous intraepithelial lesions: a meta-analysis*1

1998 • 430 citations

Management of women who test positive for high-risk types of human papillomavirus: the HART study

2004 • 428 citations

A Prospective Study of Age Trends in Cervical Human Papillomavirus Acquisition and Persistence in Guanacaste, Costa Rica

2005 • 405 citations

Incidence, Duration, and Determinants of Cervical Human Papillomavirus Infection in a Cohort of Colombian Women with Normal Cytological Results

2004 • 395 citations

Differential cytokine expression in avian cells in response to invasion by Salmonella typhimurium, Salmonella enteritidis and Salmonella gallinarum The GenBank accession numbers for the sequences reported in this paper are AI982185 for chicken IL-6 cDNA and AJ250838 for the partial chicken IL-6 genomic sequence, respectively.

2000 • 393 citations

Evaluating Human Papillomavirus Vaccination Programs

2004 • 388 citations

Toll-Like Receptor 4, But Not Toll-Like Receptor 2, Is a Signaling Receptor forEscherichiaandSalmonellaLipopolysaccharides

2000 • 352 citations

Human Papillomavirus Infection and Time to Progression and Regression of Cervical Intraepithelial Neoplasia

2003 • 331 citations

Human Papillomavirus: Epidemiology and Public Health

2003 • 329 citations

Virus-like Particles of Bovine Papillomavirus Type 4 in Prophylactic and Therapeutic Immunization

1996 • 318 citations

European Code Against Cancer and scientific justification: third version (2003)

2003 • 309 citations

Monophosphoryl lipid A as an adjuvant. Past experiences and new directions.

1995 • 283 citations

Enhancement of antigen-specific immunity via the TLR4 ligands MPL™ adjuvant and Ribi.529

2003 • 236 citations

Incidence, clearance and predictors of human papillomavirus infection in women.

2003 • 231 citations

Impact of HPV infection in adolescent populations

2005 • 221 citations

Clinical utility of HPV–DNA detection: Triage of minor cervical lesions, follow-up of women treated for high-grade CIN: An update of pooled evidence

2005 • 215 citations

Monophosphoryl Lipid A as an Adjuvant

1995 • 214 citations

Immunogenicity and safety of an adjuvanted hepatitis B vaccine in pre-hemodialysis and hemodialysis patients

2005 • 207 citations

A comprehensive natural history model of HPV infection and cervical cancer to estimate the clinical impact of a prophylactic HPV‐16/18 vaccine

2003 • 203 citations

Concurrent and Sequential Acquisition of Different Genital Human Papillomavirus Types

2000 • 201 citations

2001 Consensus Guidelines for the Management of Women with Cervical Cytological Abnormalities

2002 • 200 citations

The adjuvant monophosphoryl lipid A increases the function of antigen-presenting cells

2000 • 179 citations

Diagnostic accuracy of self collected vaginal specimens for human papillomavirus compared to clinician collected human papillomavirus specimens: a meta-analysis

2005 • 171 citations

High incidence of cervical human papillomavirus infection in women during their first sexual relationship

2002 • 167 citations

Quantitative Role of the Human Papillomavirus Type 16 E5 Gene during the Productive Stage of the Viral Life Cycle

2003 • 163 citations

A systematic review of the role of human papilloma virus (HPV) testing within a cervical screening programme: summary and conclusions

2000 • 155 citations

Assembled baculovirus-expressed human papillomavirus type 11 L1 capsid protein virus-like particles are recognized by neutralizing monoclonal antibodies and induce high titres of neutralizing antibodies

1994 • 151 citations

Human papillomavirus (HPV) type 11 recombinant virus-like particles induce the formation of neutralizing antibodies and detect HPV-specific antibodies in human sera

1994 • 149 citations

Three-dimensional structure of vaccinia virus-produced human papillomavirus type 1 capsids

1994 • 133 citations

Genotyping of Human Papillomavirus in Liquid Cytology Cervical Specimens by the PGMY Line Blot Assay and the SPF ₁₀ Line Probe Assay

2002 • 131 citations

Monophosphoryl lipid A enhances mucosal and systemic immunity to vaccine antigens following intranasal administration

2000 • 130 citations

The biology of human papillomaviruses: from warts to cancer.

1993 • 117 citations

Advances in Prevention of Cervical Cancer and Other Human Papillomavirus-Related Diseases

2006 • 114 citations

Prevalence of antibodies to human papillomavirus (HPV) type 16 virus-like particles in relation to cervical HPV infection among college women

1997 • 107 citations

ACOG Practice Bulletin Number 45, August 2003: Committee on Practice Bulletins-Gynecology. Cervical Cytology Screening

2003 • 95 citations

Occurrence of Cervical Infection with Multiple Human Papillomavirus Types is Associated with Age and Cytologic Abnormalities

2003 • 89 citations

Results of Human Papillomavirus DNA Testing with the Hybrid Capture 2 Assay Are Reproducible

2002 • 83 citations

Comparison of Diagnostic Criteria of Tuberculous Meningitis in Human Immunodeficiency Virus-Infected and Uninfected Children

2006 • 81 citations

Human Papilloma Viruses and Cancer1

2015 • 73 citations

Ubiquitous presence of E6 and E7 transcripts in human papillomavirus?Positive cervical carcinomas regardless of its type

2000 • 69 citations

The role of human papillomavirus testing in cervical screening

2005 • 66 citations

Toward a reduction of the global burden of cervical cancer

2003 • 29 citations

Adenocarcinoma of the uterine cervix: the presence of human papillomavirus and the method of detection

2003 • 27 citations

An AS04-containing human papillomavirus (HPV) 16/18 vaccine for prevention of cervical cancer is immunogenic and well-tolerated in women 15–55 years old

2006 • 22 citations

Treatment of Cervical Dysplasia With Large Loop Excision of the Transformation Zone: Is Endocervical Curettage Necessary?

1996 • 10 citations